Research Reports Initiation on Healthcare Information Services Stocks -- Inovalon, Veeva Systems, WebMD Health, and athenahealth

Tuesday, March 14, 2017 Research News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, March 14, 2017 /PRNewswire/ --

On Monday, March 13, 2017, US markets saw

broad based gains with eight out of nine sectors finishing the trading sessions in green. Major US indices were mixed at the close of yesterday's session. The NASDAQ Composite ended the day at 5,875.78, up 0.24%; the Dow Jones Industrial Average edged
0.10% lower, to finish at 20,881.48; and the S&P 500 closed at 2,373.47, marginally up 0.04%. This Tuesday morning, looks at the performance of these four Healthcare Information Services stocks: Inovalon Holdings Inc. (NASDAQ: INOV), Veeva Systems Inc. (NYSE: VEEV), WebMD Health Corporation (NASDAQ: WBMD), and athenahealth Inc. (NASDAQ: ATHN). You can access our complimentary research reports on these stocks now at:


Bowie, Maryland headquartered Inovalon Holdings Inc.'s stock advanced 1.67%, to close the day at $12.20. The stock recorded a trading volume of 930,428 shares. Inovalon Holdings' shares are trading 7.54% above its 50-day moving average. Shares of the Company, which provides cloud-based data analytics and data-driven intervention platforms in the US, are trading at a PE ratio of 68.93. Additionally, the stock has a Relative Strength Index (RSI) of 61.10. Visit us today and download your complete report on INOV for free at:

Veeva Systems  

On Monday, shares in Pleasanton, California headquartered Veeva Systems Inc. ended the session 3.74% higher at $46.83 with a total volume of 1.63 million shares traded. Veeva Systems' shares have advanced 5.97% in the last one month and 7.16% in the previous three months. Furthermore, the stock has surged 75.20% in the past one year. Shares of the Company, which provides industry cloud software and data solutions for the life sciences industry in North America, European Union, Asia/Pacific, and internationally, are trading at a PE ratio of 104.07. The stock is trading 8.10% above its 50-day moving average and 17.43% above its 200-day moving average. Moreover, the Company's shares have an RSI of 71.08.

On March 01st, 2017, research firm Needham reiterated its 'Buy' rating on the Company's stock with an increase of the target price from $46 a share to $48 a share. The complimentary research report on VEEV can be accessed at:

WebMD Health  

On Monday, shares in New York headquartered WebMD Health Corp. recorded a trading volume of 318,531 shares. The stock ended the day 0.38% higher at $52.45. Shares of the Company are trading at a PE ratio of 27.96. WebMD Health's stock has advanced 3.55% in the past one month. The Company is trading above its 50-day moving average by 3.14%. Furthermore, shares of WebMD Health, which provides health information services to consumers, physicians and other healthcare professionals, employers, and health plans through its Websites, mobile platforms, and health-focused publications in the US, have an RSI of 60.63.

On February 17th, 2017, research firm Mizuho reiterated its 'Neutral' rating on the Company's stock with an increase of the target price from $52 a share to $55 a share. Register for free on and download the PDF research report on WBMD at:


Watertown, Massachusetts headquartered athenahealth Inc.'s stock finished Monday's session 1.15% lower at $113.77 with a total volume of 227,809 shares traded. athenahealth's shares have gained 20.09% in the past three months. The Company's shares are trading below its 50-day and 200-day moving averages by 2.87% and 4.55%, respectively. Shares of athenahealth, which together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems, are trading at a PE ratio of 217.95. In addition, the stock has an RSI of 43.33. Get free access to your research report on ATHN at:


Stock Callers: 

Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

SC has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: Phone number:  +44-330-808-3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Chelmsford Park SA


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store